» Articles » PMID: 31555578

The Many Faces of Obesity and Its Influence on Breast Cancer Risk

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Sep 27
PMID 31555578
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is associated with increased risk of breast and other cancers. However, the complexity of the underlying mechanisms, together with the interplay of diet and physical activity-contributing to energy balance-and the role of adipose tissue, pose challenges to our understanding of the basis of this increased risk. Epidemiologic studies have documented a higher obesity prevalence in US black women compared to white women. Elucidation of the contribution of potential biological differences among racially distinct groups to their differences in breast cancer (BC) risk and mortality have been topics of considerable interest in recent years. The racial and ethnic variation in body fat distribution may account for at least part of the differences in breast cancer rates in these populations. Yet, while black women exhibit higher rates of obesity compared to white women, this does not translate directly into higher rates of BC. In fact, overall, BC in black women occurs with a lower incidence than BC in white women. Obesity is a known risk factor for postmenopausal breast cancer, and growing evidence suggests that abdominal obesity, also known as central obesity, may increase risk for triple negative breast cancer, which is more common in premenopausal women. The positive association of postmenopausal BC risk and specifically estrogen receptor (ER)-positive BC, is presumably due largely to accumulation of estrogen in the adipose tissue of the breast and other tissues. Of the two main types of adipose tissue-subcutaneous and visceral-visceral adipocytes are more active metabolically. Such adipose tissue harbors multiple molecular entities that promote carcinogenesis: endocrine molecules/hormones, immunologic factors, inflammatory cytokines, metabolic alterations, and other components of the microenvironment. Expression of these culpable entities is largely regulated by epigenetic mechanisms. The interrelationship between these entities and drivers of epigenetic alteration are critical to the regulation of pathways connecting obesity and cancer risk. Initiatives to counteract the carcinogenic effects of obesity have primarily involved modulation of energy balance by diet. However, targeting of specific molecular abnormalities characterizing adiposity offers an alternative approach to preventing cancer. Our goal in this review is to first discuss the major mechanisms contributing to the obesity-breast cancer link. We will also consider race, specifically black/white differences, as they relate to the association of obesity with breast cancer risk. Then we will enumerate strategies targeting these mechanisms to reduce BC risk, in large part by way of dietary interventions with potential to mitigate the cancer-promoting components of adiposity.

Citing Articles

Epigenetic Landscapes of Aging in Breast Cancer Survivors: Unraveling the Impact of Therapeutic Interventions-A Scoping Review.

Nikita N, Sun Z, Sharma S, Shaver A, Seewaldt V, Lu-Yao G Cancers (Basel). 2025; 17(5).

PMID: 40075712 PMC: 11899678. DOI: 10.3390/cancers17050866.


Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence.

Bea J, Ochs-Balcom H, Valencia C, Chen Z, Blew R, Lind K JNCI Cancer Spectr. 2025; 9(1).

PMID: 39847539 PMC: 11879126. DOI: 10.1093/jncics/pkaf007.


The Group-basEd Telehealth behavioral WEight Loss Program Among Breast Cancer Survivors: A Pilot and Feasibility Study.

Allison K, McCuen-Wurst C, Raevsky A, Holmes N, Goldbach M, Guerra C Obes Sci Pract. 2024; 10(6):e70023.

PMID: 39713088 PMC: 11662970. DOI: 10.1002/osp4.70023.


Mediation effects of metabolites and sex hormones on the relationship between body mass index and breast cancer: Mendelian randomization analysis and mediation analysis.

Yang Y, Chen M, Yang W Front Oncol. 2024; 14:1449956.

PMID: 39640279 PMC: 11617525. DOI: 10.3389/fonc.2024.1449956.


Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients.

Falcon Gonzalez A, Gallegos Sancho M, Gonzalez Flores E, Galve Calvo E, Ruiz Vozmediano J, Domingo Garcia P Clin Transl Oncol. 2024; .

PMID: 39210207 DOI: 10.1007/s12094-024-03636-9.


References
1.
Ahima R, Flier J . Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000; 11(8):327-32. DOI: 10.1016/s1043-2760(00)00301-5. View

2.
Yost K, Perkins C, Cohen R, Morris C, Wright W . Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001; 12(8):703-11. DOI: 10.1023/a:1011240019516. View

3.
. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002; 25(12):2165-71. PMC: 1282458. DOI: 10.2337/diacare.25.12.2165. View

4.
Jaenisch R, Bird A . Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003; 33 Suppl:245-54. DOI: 10.1038/ng1089. View

5.
Connolly B, Barnett C, Vogt K, Li T, Stone J, Boyd N . A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer. 2003; 44(2):127-38. DOI: 10.1207/S15327914NC4402_02. View